Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Rollover Study to Provide Continued Treatment With GSK2118436 to Subjects With BRAF Mutation-Positive Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
- Status
- TERMINATED
- Phase
- NA
Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With Malaria
- Status
- COMPLETED
- Phase
- N/A
CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
- Status
- COMPLETED
- Phase
- PHASE4
A Study of the Hsp90 Inhibitor AUY922 Plus Capecitabine for the Treatment of Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
LBH Phase II in Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA Gene
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
- Status
- COMPLETED
- Phase
- PHASE3
A Study of mTOR Inhibitor Everolimus (RAD001) in Association With Cisplatin and Radiotherapy for Locally Advanced Cervix Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints
- Status
- COMPLETED
- Phase
- PHASE2
A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE4
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients
- Status
- COMPLETED
- Phase
- N/A